These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Brouwer PJM; Brinkkemper M; Maisonnasse P; Dereuddre-Bosquet N; Grobben M; Claireaux M; de Gast M; Marlin R; Chesnais V; Diry S; Allen JD; Watanabe Y; Giezen JM; Kerster G; Turner HL; van der Straten K; van der Linden CA; Aldon Y; Naninck T; Bontjer I; Burger JA; Poniman M; Mykytyn AZ; Okba NMA; Schermer EE; van Breemen MJ; Ravichandran R; Caniels TG; van Schooten J; Kahlaoui N; Contreras V; Lemaître J; Chapon C; Fang RHT; Villaudy J; Sliepen K; van der Velden YU; Haagmans BL; de Bree GJ; Ginoux E; Ward AB; Crispin M; King NP; van der Werf S; van Gils MJ; Le Grand R; Sanders RW Cell; 2021 Mar; 184(5):1188-1200.e19. PubMed ID: 33577765 [TBL] [Abstract][Full Text] [Related]
44. The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity. Tejedor Vaquero S; de Campos-Mata L; Ramada JM; Díaz P; Navarro-Barriuso J; Ribas-Llaurado C; Rodrigo Melero N; Carolis C; Cerutti A; Gimeno R; Magri G Front Immunol; 2021; 12():737083. PubMed ID: 34539673 [TBL] [Abstract][Full Text] [Related]
45. Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers. Khan MS; Kim E; Hingrat QL; Kleinman A; Ferrari A; Sammartino JC; Percivalle E; Xu C; Huang S; Kenniston TW; Cassaniti I; Baldanti F; Pandrea I; Gambotto A; Apetrei C bioRxiv; 2023 Mar; ():. PubMed ID: 36993692 [TBL] [Abstract][Full Text] [Related]
46. Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine. Jangra S; De Vrieze J; Choi A; Rathnasinghe R; Laghlali G; Uvyn A; Van Herck S; Nuhn L; Deswarte K; Zhong Z; Sanders N; Lienenklaus S; David S; Strohmeier S; Amanat F; Krammer F; Hammad H; Lambrecht BN; Coughlan L; García-Sastre A; De Geest BG; Schotsaert M bioRxiv; 2020 Oct; ():. PubMed ID: 33106810 [TBL] [Abstract][Full Text] [Related]
47. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques. O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH Front Immunol; 2021; 12():800723. PubMed ID: 34992610 [TBL] [Abstract][Full Text] [Related]
48. Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Royal JM; Simpson CA; McCormick AA; Phillips A; Hume S; Morton J; Shepherd J; Oh Y; Swope K; DeBeauchamp JL; Webby RJ; Cross RW; Borisevich V; Geisbert TW; Demarco JK; Bratcher B; Haydon H; Pogue GP Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835278 [TBL] [Abstract][Full Text] [Related]
49. Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates. Ma Q; Li R; Guo J; Li M; Ma L; Dai J; Shi Y; Dai J; Huang Y; Dai C; Pan W; Zhong H; Zhang H; Wen J; Zhao H; Wu L; Yang W; Zhang B; Yang Z Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298563 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM Elife; 2022 Jan; 11():. PubMed ID: 35072628 [TBL] [Abstract][Full Text] [Related]
51. A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats. Tabynov K; Orynbassar M; Yelchibayeva L; Turebekov N; Yerubayev T; Matikhan N; Yespolov T; Petrovsky N; Tabynov K Front Vet Sci; 2022; 9():815978. PubMed ID: 35372556 [TBL] [Abstract][Full Text] [Related]
52. Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity. Scaglione A; Opp S; Hurtado A; Lin Z; Pampeno C; Noval MG; Thannickal SA; Stapleford KA; Meruelo D Front Immunol; 2021; 12():719077. PubMed ID: 34394127 [TBL] [Abstract][Full Text] [Related]
53. Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA. Liu Y; Dai L; Feng X; Gao R; Zhang N; Wang B; Han J; Zou Q; Guo X; Zhu H; Liu J; Qin C; Zhang Y; Bao L; Li M Mol Biomed; 2021; 2(1):29. PubMed ID: 34766005 [TBL] [Abstract][Full Text] [Related]